Computer-aided detection and localization of distal radius fractures on adult wrist PA/LAT radiographs as an adjunct to clinician review.
Clinical role
Concurrent assisted-read detection and localization in PACS; annotated and original images are read together, and the device is adjunctive rather than a replacement for clinician review.
Images and patients
X-ray/Radiography · Adult wrist, specifically the distal radius
Key limitation
Clinicians must read the annotation concurrently with the original and must not use it as the primary interpretation. OsteoDetect is not designed for fractures other than distal radius fractures, may not detect a fracture in both PA and LAT views, and requires proper DICOM tags. It supports only the three named imaging systems; motion, incompatible hardware or parameters, false positives, false negatives, missing/delayed results, and incorrect results are identified risks.
Overview status: Field-derived fact summary This section is assembled from the sourced field records below; it is not a source-reviewed editorial overview.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Imaging and anatomyX-ray/Radiography · Adult wrist, specifically the distal radius
Workflow roleConcurrent assisted-read detection and localization in PACS; annotated and original images are read together, and the device is adjunctive rather than a replacement for clinician review.
Required inputPA and LAT wrist radiographs of adults aged 22 and older, represented as CR/DR DICOM objects with proper tags, acquired on Philips Medical Systems DigitalDiagnost, Carestream Health DRX-1, or GE Discovery XR656; input filtering uses image characteristics and DICOM tags.
Output and human actionAn annotated DICOM radiograph is returned to the same patient study as the original. A detected case receives a bounding box and the label Distal Radius Fracture: DETECTED; a negative case receives Distal Radius Fracture: NOT DETECTED, along with an analysis message and labeling instructions. The algorithm also generates a confidence score and conditional probability map for localization.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Computer-aided detection and localization of distal radius fractures on adult wrist PA/LAT radiographs as an adjunct to clinician review.
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Concurrent assisted-read detection and localization in PACS; annotated and original images are read together, and the device is adjunctive rather than a replacement for clinician review.
PA and LAT wrist radiographs of adults aged 22 and older, represented as CR/DR DICOM objects with proper tags, acquired on Philips Medical Systems DigitalDiagnost, Carestream Health DRX-1, or GE Discovery XR656; input filtering uses image characteristics and DICOM tags.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
An annotated DICOM radiograph is returned to the same patient study as the original. A detected case receives a bounding box and the label Distal Radius Fracture: DETECTED; a negative case receives Distal Radius Fracture: NOT DETECTED, along with an analysis message and labeling instructions. The algorithm also generates a confidence score and conditional probability map for localization.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Clinicians must read the annotation concurrently with the original and must not use it as the primary interpretation. OsteoDetect is not designed for fractures other than distal radius fractures, may not detect a fracture in both PA and LAT views, and requires proper DICOM tags. It supports only the three named imaging systems; motion, incompatible hardware or parameters, false positives, false negatives, missing/delayed results, and incorrect results are identified risks.
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Standalone testing used an independent set of 1,000 images (500 PA and 500 LAT), with ground truth from three US board-certified orthopedic hand surgeons by majority opinion. FDA reported AUC 0.965 (95% CI: 0.953-0.976), sensitivity 0.921 (95% CI: 0.886-0.946), specificity 0.902 (95% CI: 0.877-0.922), PPV 0.813 (95% CI: 0.769-0.850), NPV 0.961 (95% CI: 0.943-0.973), and mean localization centroid distance 33.52 pixels (SD 30.03). A separate 24-reader, 200-case MRMC study reported an aided-versus-unaided AUC difference of 0.049 (95% CI: 0.019-0.080; p=0.0056); aided sensitivity was 0.803 (95% CI: 0.785-0.819) and aided specificity was 0.914 (95% CI: 0.903-0.924).
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Standalone testing used an independent set of 1,000 images (500 PA and 500 LAT), with ground truth from three US board-certified orthopedic hand surgeons by majority opinion. FDA reported AUC 0.965 (95% CI: 0.953-0.976), sensitivity 0.921 (95% CI: 0.886-0.946), specificity 0.902 (95% CI: 0.877-0.922), PPV 0.813 (95% CI: 0.769-0.850), NPV 0.961 (95% CI: 0.943-0.973), and mean localization centroid distance 33.52 pixels (SD 30.03). A separate 24-reader, 200-case MRMC study reported an aided-versus-unaided AUC difference of 0.049 (95% CI: 0.019-0.080; p=0.0056); aided sensitivity was 0.803 (95% CI: 0.785-0.819) and aided specificity was 0.914 (95% CI: 0.903-0.924).
FDA source
Exact FDA submission
Checked 2026-09-19
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
OsteoDetect regulatory performance study summary
DesignStand-alone performance and reader study (ACR AI Central category)
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission DEN180005
Samplen=1000
IndependenceIndependence not established
DEN180005
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for DEN180005. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: PA and LAT wrist radiographs of adults aged 22 and older, represented as CR/DR DICOM objects with proper tags, acquired on Philips Medical Systems DigitalDiagnost, Carestream Health DRX-1, or GE Discovery XR656; input filtering uses image characteristics and DICOM tags.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM Network Input and Output connect the device with a DICOM Storage Server, and the facility PACS displays annotated and original images for concurrent reading. The packet specifies a dedicated physical machine with at least 2 CPU cores, 16 GB RAM, 100 GB free space, 100 Mbps Ethernet, and vSphere ESXi 6.0 Update 2; a specific PACS product interface is not established.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-09 ·
Returned objects
Source context, not route validation: An annotated DICOM radiograph is returned to the same patient study as the original. A detected case receives a bounding box and the label Distal Radius Fracture: DETECTED; a negative case receives Distal Radius Fracture: NOT DETECTED, along with an analysis message and labeling instructions. The algorithm also generates a confidence score and conditional probability map for localization.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: An annotated DICOM radiograph is returned to the same patient study as the original. A detected case receives a bounding box and the label Distal Radius Fracture: DETECTED; a negative case receives Distal Radius Fracture: NOT DETECTED, along with an analysis message and labeling instructions. The algorithm also generates a confidence score and conditional probability map for localization.
Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
DICOM Network Input and Output connect the device with a DICOM Storage Server, and the facility PACS displays annotated and original images for concurrent reading. The packet specifies a dedicated physical machine with at least 2 CPU cores, 16 GB RAM, 100 GB free space, 100 Mbps Ethernet, and vSphere ESXi 6.0 Update 2; a specific PACS product interface is not established.
Imagen's security policy (effective 2024-04-02) states HIPAA, HITRUST CSF and SOC 2 Type II compliance, encryption in transit and at rest, least-privilege access, multi-factor authentication, audit trails and incident response. Vendor statement; no report or certificate was read.
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: the policy is on imagen.ai, whose AI software page lists this product by name, and the FDA letter for this entry names Imagen Technologies, Inc. (New York). The policy is company-wide; exact-release scope is not established. A 2023 HITRUST release names the Care Delivery Services platform, not the devices, and is not applied.
The De Novo decision summary states that the OsteoDetect user manual specifies radiology technologist training requirements to ensure that the appropriate metadata tags are applied to all cases so that the device can correctly identify images to be analyzed. The special controls also require labeling to include a detailed description of the intended user and any user training materials.
Exact FDA submission
Checked 2026-10-27
Training requirement stated via the device user manual (radiology technologist training for correct metadata tagging); the summary describes no vendor-provided training program beyond the user manual.
ACR AI Central provides an exact-submission model card for OsteoDetect; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-19Last searched
26Fields reviewed
11Source classes checked
1Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads
Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA packet assessed on 2026-09-19. Directory-backed facts were reconciled only where purpose, modality, and anatomy were each directly established. Candidate literature and postmarket candidates remain in their existing review state. Automated exact-name discovery found 1 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads remain unpublished until a human confirms the exact product and tested version.
Source classes: fda ai list, fda decision summary, acr ai central product, fda de novo summary, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission
No public price or quote for the exact DEN180005 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-09 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.
Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.
Authorized purpose: Aids clinicians and radiologists reviewing 2D X-ray radiographs by detecting, localizing, and characterizing fractures across the FDA-listed appendicular, hip/pelvis, clavicle, and thorax/rib examinations, and by detecting elbow joint effusion on lateral elbow or forearm views in children/adolescents and adults; results are not standalone clinical decisions.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.